Literature DB >> 1718763

Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation.

L C Burkly1, A Jakubowski, B M Newman, M D Rosa, G Chi-Rosso, R R Lobb.   

Abstract

Vascular cell adhesion molecule, VCAM-1, is an adhesion molecule expressed on activated endothelium thought to play a role in leukocyte migration to sites of inflammation. VCAM-1 adheres to leukocytes through the VLA-4 integrin. Recombinant soluble VCAM-1 (rsVCAM) and anti-CD3 mAb OKT3 were utilized to address the role of the VCAM-1/VLA-4 pathway in antigen-dependent T cell activation. Monocyte-depleted T cells proliferated upon exposure to co-immobilized OKT3 and rsVCAM but to neither alone. In contrast, an anti-VLA-4 mAb HP1/2 failed to co-activate with OKT3, despite the fact that both rsVCAM and HP1/2 support T cell adhesion comparably. These data indicate that adhesive function is not sufficient for co-stimulatory activity. They also reveal that VCAM-1 may play a role in regulating T cell immune responses as well as migration in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718763     DOI: 10.1002/eji.1830211132

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  Convergence between CD98 and integrin-mediated T-lymphocyte co-stimulation.

Authors:  A P Warren; K Patel; Y Miyamoto; J N Wygant; D G Woodside; B W McIntyre
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 3.  Diverse roles of integrins in human T lymphocyte biology.

Authors:  Yuko J Miyamoto; Bernard F Andruss; Jason S Mitchell; Matthew J Billard; Bradley W McIntyre
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Ozgür Yaldizli; Norman Putzki
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

5.  Expression of ICAM-1, ICAM-2, NCAM-1 and VCAM-1 by human synovial cells exposed to Borrelia burgdorferi in vitro.

Authors:  Sunit K Singh; Verena Baar; Henner Morbach; Hermann J Girschick
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

Review 6.  The pathophysiologic role of alpha 4 integrins in vivo.

Authors:  R R Lobb; M E Hemler
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection.

Authors:  C E Bacchi; C L Marsh; J D Perkins; R L Carithers; J P McVicar; K L Hudkins; C D Benjamin; J M Harlan; R Lobb; C E Alpers
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Predominant role of alpha 4-integrins for distinct steps of lymphoma metastasis.

Authors:  U Gosslar; P Jonas; A Luz; A Lifka; D Naor; A Hamann; B Holzmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 9.  The vitronectin receptor (alpha V beta 3) as an example for the role of integrins in T lymphocyte stimulation.

Authors:  M J Halvorson; J E Coligan; K Sturmhöfel
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

10.  Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein.

Authors:  R W Terry; L Kwee; J F Levine; M A Labow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.